Ping An Biomedical Seeks Vote to Lift Authorized Capital to US$12.5M and Pre-Approve Further Reverse Splits
PASW sits 62% above its 52-week low of $3.07 on light trading volume (0.1× avg).
Summary
Ping An Biomedical's October 29 extraordinary meeting will ratify the already-executed 1-for-40 reverse split and, more importantly, vote to raise authorized capital to US$12.5 million and pre-approve further consolidations of up to 80:1 if the share price falls below US$1.00.
Key Events · Corporate Governance and Compliance · PASW
-
Authorized Capital to Rise to US$12.5M
Proposal Three would lift authorized capital from US$312,500 (122,500,000 class A and 2,500,000 class B at US$0.0025 par) to US$12,500,000 (4,900,000,000 class A and 100,000,000 class B), creating 4,777,500,000 new class A and 97,500,000 new class B authorized shares.
-
No Shares Sold in This Filing
The proposals only grant permission to issue; the filing contains no transaction data, price or proceeds. Any future issuance off this authorization would be dilutive.
-
Contingent Further Consolidations Pre-Approved
Proposal Five authorizes 10:1, 20:1, 50:1 or 80:1 consolidations triggered if the class A closing price stays below US$1.00 for 20 consecutive trading days (5 days for the 80:1 tier) and lands in the specified price bands.
-
Meeting and Record Dates
The extraordinary general meeting is set for October 29, 2026 in Hong Kong, with a record date of September 29, 2026; the 1-for-40 consolidation it ratifies took effect October 23, 2026.
Analysis · PASW · Manufacturing
The ratification vote is housekeeping: the 1-for-40 reverse split was announced on October 21 and took effect October 23. What matters is the scale of the authorized-share increase. The board wants authority for 4.9 billion class A shares at US$0.0025 par, up from 122.5 million, restoring a very large pool of unissued stock just two days after the company filed a $300 million shelf. Proposal Five adds contingent authority to consolidate shares again at 10:1 up to 80:1 if the price falls back under US$1.00. Together, the package gives management broad room to issue equity and to defend the Nasdaq minimum-bid requirement without another shareholder vote. Existing holders are not diluted today — no shares are being sold here — but the authorized headroom is enormous relative to the current share count, and the contingent split authority is a standing reminder that the listing is still fragile.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PASW was trading at $4.97 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $14M. The 52-week trading range was $3.07 to $30.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.